SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 287 filers reported holding SAGE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $426,088 | -72.8% | 20,704 | -37.9% | 0.00% | -80.0% |
Q2 2023 | $1,566,753 | +578.9% | 33,321 | +505.8% | 0.01% | – |
Q1 2023 | $230,780 | -25.3% | 5,500 | -32.1% | 0.00% | – |
Q4 2022 | $308,934 | -63.7% | 8,100 | -57.8% | 0.00% | -100.0% |
Q3 2021 | $851,000 | +29.1% | 19,200 | +65.5% | 0.00% | 0.0% |
Q2 2021 | $659,000 | -72.7% | 11,600 | -64.0% | 0.00% | -72.7% |
Q1 2021 | $2,415,000 | +105.2% | 32,265 | +137.2% | 0.01% | +120.0% |
Q4 2020 | $1,177,000 | +263.3% | 13,600 | +156.6% | 0.01% | +150.0% |
Q3 2020 | $324,000 | -78.2% | 5,300 | -85.2% | 0.00% | -77.8% |
Q2 2020 | $1,484,000 | +63.3% | 35,700 | +12.8% | 0.01% | +50.0% |
Q1 2020 | $909,000 | +16.7% | 31,636 | +192.9% | 0.01% | 0.0% |
Q4 2019 | $779,000 | -81.4% | 10,800 | -63.9% | 0.01% | -83.3% |
Q3 2019 | $4,196,000 | -17.0% | 29,901 | +8.3% | 0.04% | -16.3% |
Q2 2019 | $5,056,000 | +2015.5% | 27,616 | +1741.1% | 0.04% | +2050.0% |
Q1 2019 | $239,000 | -92.4% | 1,500 | -93.3% | 0.00% | -88.2% |
Q3 2018 | $3,150,000 | +8900.0% | 22,300 | +3567.8% | 0.02% | – |
Q4 2015 | $35,000 | – | 608 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 312,000 | $29,886,000 | 5.11% |
DAFNA Capital Management LLC | 104,306 | $9,991,000 | 4.97% |
Palo Alto Investors LP | 850,977 | $81,515,000 | 4.34% |
BB BIOTECH AG | 1,375,229 | $131,733,000 | 4.22% |
Eventide Asset Management | 936,000 | $89,659,000 | 3.97% |
TRV GP II, LLC | 37,362 | $3,579,000 | 3.56% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 146,179 | $14,002,000 | 2.11% |
SUFFOLK CAPITAL MANAGEMENT LLC | 111,908 | $10,720,000 | 2.06% |
OAK RIDGE INVESTMENTS LLC | 231,483 | $22,174,000 | 1.60% |
Rhenman & Partners Asset Management AB | 137,339 | $13,156,000 | 1.50% |